非布司他在痛风石性痛风患者中降尿酸的临床疗效观察

被引:2
作者
邓琼
徐朝焰
机构
[1] 福建医科大学附属三明第一医院
关键词
痛风; 痛风石; 非布司他; 尿酸;
D O I
10.19435/j.1672-1721.2018.25.036
中图分类号
R589.7 [嘌呤(Purine)代谢障碍];
学科分类号
100201 [内科学];
摘要
目的探讨非布司他在痛风石性痛风患者中降尿酸的临床疗效。方法选取2016年1月—7月在我院诊治的70例痛风石性痛风患者,随机将其分成观察与对照组,每组35例。观察组口服非布司他治疗,对照组口服别嘌醇治疗,分别检测2组患者治疗前后血尿酸水平,并记录20个星期后血尿酸水平<300μmol/L的例数。结果治疗后2组患者血尿酸水平均较治疗前降低,并且观察组患者血尿酸含量明显低于对照组,差异有统计学意义(P<0.05);20个星期后观察组患者血尿酸水平低于300μmol/L的例数多于对照组,差异有统计学意义(P<0.05)。结论非布司他治疗痛风石性痛风,可有效降低尿酸,安全性高,值得推广应用。
引用
收藏
页码:3552 / 3554
页数:3
相关论文
共 10 条
[1]
2016中国痛风诊疗指南.[J].中华医学会风湿病学分会;.中华内科杂志.2016, 11
[2]
别嘌醇超敏反应研究进展 [J].
陈泽娜 ;
古洁若 .
新医学, 2016, 47 (03) :142-145
[3]
难治性痛风石性痛风的治疗 [J].
刘湘源 .
中华临床医师杂志(电子版), 2008, (06) :619-623
[4]
Toward Development of a Tophus Impact Questionnaire A Qualitative Study Exploring the Experience of People With Tophaceous Gout [J].
Aati, Opetaia ;
Taylor, William J. ;
Horne, Anne ;
Dalbeth, Nicola .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (05) :251-255
[5]
Diabetes and gout: efficacy and safety of febuxostat and allopurinol [J].
Becker, M. A. ;
MacDonald, P. A. ;
Hunt, B. J. ;
Jackson, R. L. .
DIABETES OBESITY & METABOLISM, 2013, 15 (11) :1049-1055
[6]
Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response [J].
Yun, J. ;
Mattsson, J. ;
Schnyder, K. ;
Fontana, S. ;
Largiader, C. R. ;
Pichler, W. J. ;
Yerly, D. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (11) :1246-1255
[7]
Chronic gout in the elderly [J].
Bolzetta, Francesco ;
Veronese, Nicola ;
Manzato, Enzo ;
Sergi, Giuseppe .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 25 (02) :129-137
[8]
2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis [J].
Khanna, Dinesh ;
Khanna, Puja P. ;
Fitzgerald, John D. ;
Singh, Manjit K. ;
Bae, Sangmee ;
Neogi, Tuhina ;
Pillinger, Michael H. ;
Merill, Joan ;
Lee, Susan ;
Prakash, Shraddha ;
Kaldas, Marian ;
Gogia, Maneesh ;
Perez-Ruiz, Fernando ;
Taylor, Will ;
Liote, Frederic ;
Choi, Hyon ;
Singh, Jasvinder A. ;
Dalbeth, Nicola ;
Kaplan, Sanford ;
Niyyar, Vandana ;
Jones, Danielle ;
Yarows, Steven A. ;
Roessler, Blake ;
Kerr, Gail ;
King, Charles ;
Levy, Gerald ;
Furst, Daniel E. ;
Edwards, N. Lawrence ;
Mandell, Brian ;
Schumacher, H. Ralph ;
Robbins, Mark ;
Wenger, Neil ;
Terkeltaub, Robert .
ARTHRITIS CARE & RESEARCH, 2012, 64 (10) :1447-1461
[9]
A Repeated Oral Administration Study of Febuxostat (TMX-67); a Non-Purine-Selective Inhibitor of Xanthine Oxidase; in Patients With Impaired Renal Function in Japan: Pharmacokinetic and Pharmacodynamic Study.[J].Hosoya Tatsuo;Ohno Iwao.Journal of Clinical Rheumatology.2011, 4 Su
[10]
内科学.[M].叶任高等; 编著.人民卫生出版社.2004,